Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Bactroban Ointment (mupirocin), 2% SmithKline Beecham NDA 50-591/S-22 Mupirocin Ointment, 2%, Clay-Park Labs, NDA 50-788 MUPIROCIN Ointment; Topical 2% BACTROBAN GLAXOSMITHKLINE 050788 BX MUPIROCIN Ointment; Topical 2% MUPIROCIN JOHNSON AND JOHNSON 050746 MUPIROCIN CALCIUM Cream, Augmented; Topical 2% BACTROBAN GLAXOSMITHKLINE 050703 MUPIROCIN CALCIUM Ointment; Nasal 2% BASE BACTROBAN GLAXOSMITHKLINE Mupirocin Ointment, Teva Mupirocin Ointment, Clay-Park Labs | Mupirocin Ointment, Taro Pharmaceuticals, Approval | Mupirocin Ointment, Altana Inc., Approval 065192 ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com